In the afternoon of July 22, the American Cancer Society instructed the staff of its National Home Office to pick up their belongings and equipment before July 30.
The FDA Oncologic Drugs Advisory Committee July 25 voted unanimously to set more rigorous standards for new trials for approval of perioperative indications of cancer drugs.
